News & Events

July 26, 2011
Alper Biotech announces a distribution agreement with Fisher Scientific to market Alper Biotech’s immunohistochemistry and R&D kits.

June 22, 2011
Alper Biotech launches product line of research and development kits using monoclonal antibodies for applications in Western Blot, Indirect-Immunofluourescence and Flow Cytometry analytic techniques.

June 14, 2011
Alper Biotech CEO Özge Alper participates in healthcare roundtable sponsored by JP Morgan.

March 2011
Alper Biotech and Harvard Medical School pursuing collaborative research on filamin A protein specific to breast cancer.

April 17, 2010
Alper Biotech launches its Immunohistochemistry (IHC) Kits, used in cancer for diagnosis, staging, prognosis and directing treatment.

January 15, 2008
Alper Biotech launches its online store with its first product

October 19, 2007
Alper Biotech moves into the the Maryland Technology Development Center (MTDC)

June 30, 2007
Alper Biotech is certified by the State of Maryland as a Qualified Biotechnology Company